en

PRODUCT DETAIL

Sitagliptin Medreg

Code 1236F
MA number 18/0320/25-S
Product Form: tbl flm 28x100 mg (blis.PVC/PE/PVDC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: Medreg s.r.o., Czechia
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B Blood glucose lowering drugs, excl. insulins
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH01 Sitagliptin
Shelf life: 30
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 15.10.2025
Validity: 15.10.2030
SPC: SPC_Sitagliptin Medreg_09 2025.pdf  
PIL: PIL_Sitagliptin Medreg_10_2025.pdf  
Safety feature Yes
Data update: 21.10.2025
eu-flag.png sk-flag.png